← Back to Search

Clinical Tool for Cystic Fibrosis Waitlist Mortality

N/A

Recruiting

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

To be listed for lung transplant

Diagnosis of Cystic Fibrosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 1 year

Awards & highlights

Study Summary

This trial aimed to improve waitlist mortality in patients with cystic fibrosis by implementing a clinical tool.

Who is the study for?

This trial is for individuals with Cystic Fibrosis who are on the waitlist for a lung transplant and have bought a home spirometer. It's not suitable for those without Cystic Fibrosis, or people who can't read or use a computer/smartphone to access the required mobile app.Check my eligibility

What is being tested?

The study is testing a clinical tool that includes mobile spirometry (a way to measure lung function) and surveys. The goal is to see if this tool can help reduce the number of patients with Cystic Fibrosis who die while waiting for a lung transplant.See study design

What are the potential side effects?

Since this trial involves using a clinical tool rather than medication, traditional side effects like you'd expect from drugs aren't applicable here. However, there may be indirect effects related to data privacy concerns or stress from constant health monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am on the waiting list for a lung transplant.

Select...

I have been diagnosed with Cystic Fibrosis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lung Allocation Score (LAS)

Secondary outcome measures

Transplantation

Time to transplant

Trial Design

1Treatment groups

Experimental Treatment

Group I: Clinical Tool (Mobile Spirometry and Survey)Experimental Treatment1 Intervention

All subjects enrolled will be placed into the clinical tool arm. The clinical tool is comprised of a mobile application based assessment of home spirometry and a survey measuring patient reported outcomes.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor

1,027 Previous Clinical Trials

1,366,158 Total Patients Enrolled

Media Library

Clinical Tool (Mobile Spirometry and Survey) Clinical Trial Eligibility Overview. Trial Name: NCT04687475 — N/A

Cystic Fibrosis Research Study Groups: Clinical Tool (Mobile Spirometry and Survey)

Cystic Fibrosis Clinical Trial 2023: Clinical Tool (Mobile Spirometry and Survey) Highlights & Side Effects. Trial Name: NCT04687475 — N/A

Clinical Tool (Mobile Spirometry and Survey) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04687475 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the population size of this research project?

"Affirmative. Clinicaltrials.gov data suggests that this medical trial is recruiting participants; it was first published on April 20th 2020 and most recently edited on July 6th 2022, with the aim of admitting 43 people at a single location."

Answered by AI

Are there any unfilled vacancies in this research endeavor?

"Affirmative. The clinical trial, which was initially advertised on April 20th 2020, is still recruiting volunteers. 43 participants are needed at 1 designated location and the details have been updated as recently as July 6th 2022 according to information hosted on clinicaltrials.gov."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

2020. "Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04687475.

All > Cystic Fibrosis